series-a
Stage
1
Investors
About
Tectonic Therapeutic is a clinical-stage biotechnology company developing therapeutic proteins and antibodies that target G-Protein Coupled Receptors (GPCRs) using their proprietary GEODe™ platform to address diseases with unmet medical needs.
Explore Tectonic Therapeutic's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.